91 related articles for article (PubMed ID: 1766737)
1. [Effects of immunologic markers on prognosis in acute lymphoblastic leukemia in young children].
Balakirev SA; Makhonova LA; Tupitsyn NN; Baryshnikov AIu; Artem'ev AK; Maiakova SA; Kadagidze ZG
Pediatriia; 1991; (11):37-9. PubMed ID: 1766737
[TBL] [Abstract][Full Text] [Related]
2. [Incidence, clinical markers and prognostic significance of immunologic subtypes of acute lymphoblastic leukemia (ALL) in children: experiences of the ALL-BFM 83 and 86 studies].
Ludwig WD; Teichmann JV; Sperling C; Komischke B; Ritter J; Reiter A; Odenwald E; Sauter S; Riehm H
Klin Padiatr; 1990; 202(4):243-52. PubMed ID: 2203938
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics and prognosis of various immunocytological subvariants of acute lymphoblastic leukemia in children].
Klubovskaia NI; Tsveĭbakh AS; Petrova EM; Pustovalova AG; Bessonova AG
Pediatriia; 1989; (2):30-4. PubMed ID: 2726363
[TBL] [Abstract][Full Text] [Related]
4. [Use of monoclonal antibodies in acute lymphoblastic leukemia in children. I. Immunological subclassification of acute lymphoblastic leukemia].
Kołecki P; Radwańska U
Pediatr Pol; 1988 Nov; 63(11):693-7. PubMed ID: 3253655
[No Abstract] [Full Text] [Related]
5. [Glucocorticoid receptors in acute lymphoblastic leukemia in children].
Gershteĭn ES; Moiseenko EI; Tupitsyn NN; Bassalyk LS
Pediatriia; 1991; (11):63-7. PubMed ID: 1766744
[TBL] [Abstract][Full Text] [Related]
6. [Acute lymphoblastic leukemia with Philadelphia chromosome: eight case reports].
Laatiri MA; Chehata S; Amouri A; Sendi HS; Saad A; Ennabli S
Tunis Med; 2001 Jan; 79(1):38-41. PubMed ID: 11332342
[TBL] [Abstract][Full Text] [Related]
7. [Specific features of stem cell (CD34+) subvariant of acute lymphoblast cell leukemia in children].
Maiakova SA; Tupitsyn NN; Gavrikova NV; Popa AV; Kurdiukov BV; Serebriakova IN; Kurmashov VI
Vestn Ross Akad Med Nauk; 2000; (6):38-41. PubMed ID: 10943162
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute lymphoblastic leukemia.
Ludwig WD; Bartram CR; Harbott J; Köller U; Haas OA; Hansen-Hagge T; Heil G; Seibt-Jung H; Teichmann JV; Ritter J
Leukemia; 1989 Jun; 3(6):431-9. PubMed ID: 2725059
[TBL] [Abstract][Full Text] [Related]
9. Definition of acute biphenotypic leukemia.
Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
[TBL] [Abstract][Full Text] [Related]
10. Expression of a novel surface antigen MKW in childhood acute leukemia has prognostic significance.
Koehler M; Schell MJ; Behm FG; Raimondi SC; Woodruff LS; Mirro J
Leukemia; 1991 Jan; 5(1):41-8. PubMed ID: 1999957
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotyping of childhood acute lymphoblastic leukemia in Saudi Arabia: second look.
Khalil SH; Qari MH; Jackson JM; Pyle RH; el-Solh H; al-Nasser A
Leuk Res; 1994 Dec; 18(12):881-3. PubMed ID: 7996868
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
14. [Intracellular retention of cytarabine-triphosphate (Ara-CTP) in blasts of children with acute lymphoblastic leukemia. Correlation with clinical course parameters].
Schiller M; Hohenlöchter B; Schulze-Westhoff P; Zimmermann M; Ritter J; Jürgens H; Boos J
Klin Padiatr; 1996; 208(4):151-9. PubMed ID: 8926681
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of standard CD assessment in acute leukemia.
Tupitsyn NN; Babusíková O; Baryshnikov AYu ; Ujházy P; Kadagidze ZG; Mahonova LA; Peterson IS; Protasova AK; Drozdova TS; Artemjev AK
Neoplasma; 1990; 37(4):431-8. PubMed ID: 2146517
[TBL] [Abstract][Full Text] [Related]
16. [An analysis of prognostic factors for acute leukemia patients with 5-year long-term survival in Shanghai].
Wang X; Lin G; Wang J; Wang Q; Lin P
Zhonghua Nei Ke Za Zhi; 1999 Dec; 38(12):827-31. PubMed ID: 11798727
[TBL] [Abstract][Full Text] [Related]
17. [Monoclonal antibodies ICO-11 in the prognostic evaluation of acute nonlymphoblastic leukemia].
Tupitsyn NN; Volkova MA; Perilov AA; Artem'ev AK
Gematol Transfuziol; 1990 Aug; 35(8):7-9. PubMed ID: 2253864
[TBL] [Abstract][Full Text] [Related]
18. Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome.
Thomas X; Thiebaut A; Olteanu N; Danaïla C; Charrin C; Archimbaud E; Fiere D
Hematol Cell Ther; 1998 Jun; 40(3):119-28. PubMed ID: 9698220
[TBL] [Abstract][Full Text] [Related]
19. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
Wiersma SR; Ortega J; Sobel E; Weinberg KI
N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
[TBL] [Abstract][Full Text] [Related]
20. Pre-existing malnutrition and treatment outcome in children with acute lymphoblastic leukaemia.
Khan AU; Sheikh MU; Intekhab K
J Pak Med Assoc; 2006 Apr; 56(4):171-3. PubMed ID: 16711338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
